Considering the NT-proBNP levels in patients who underwent intravenous thrombolysis, one study reported that NT-proBNP levels were associated with 3-month mortality in patients with stroke who underwent intravenous thrombolysis (OR 1.334, 95% CI 1.020–1.745) (Zhang X. et al., 2021). This evidence concerns the gene NPPB and stroke disorder.